Schizophrenia is a mental disorder typified by poor emotional responsiveness and a breakdown of thought processes. Symptoms associated with schizophrenia include disorganized thinking and speech, hallucinations, bizarre and paranoid delusions, and is complemented by considerable occupational or social dysfunction. Early environment, genetics, neurobiology, social, and psychological process are the key contributors to schizophrenia. Schizophrenia is assumed to affect thought processes. In addition, schizophrenia plays a part to chronic issues with emotions and behavior. Individuals suffering from schizophrenia have probable conditions, for example, anxiety disorders and major depression disorders. In addition, people suffering from schizophrenia abuse substances and are placed at 50%. Also, these people suffer from problems, for example, homelessness, long term unemployment, and poverty. The standard life expectancy of people suffering from schizophrenia is approximately 12 years less than those who do not suffer from schizophrenia. The start of symptoms related to schizophrenia appears in young adulthood. The worldwide life prevalence of schizophrenia ranges from 0.3% to 0.7% (Mueser & Jeste, 2008). The prime schizophrenia treatment is an antipsychotic medication merged with social and psychological supports. In addition, hospitalization may take place for critical cases either involuntarily and voluntarily. Community support services are also common; they include supported employment,
drop-in centers, support groups, and visits by people from a community mental health group. In addition, a number of researches assert that frequent practice has a positive impact on the mental and physical condition of schizophrenia patients. Antipsychotic medication can decrease the psychosis positive symptoms in almost one to two weeks.